search
EN
VI
Home
Introduction
Products
Research and development
News
Shareholders relations
close
search
Home
News
Company News
Industry News
Health News
Careers
News
11.14.2022
New treatment option for schizophrenia - Reagila (Cariprazine)
Schizophrenia is a serious psychiatric disorder that affects a person's behavior, thoughts, and feelings, and how they perceive, assess reality and social interaction. Schizophrenia includes a range of symptoms such as hallucinations, delusions, restlessness, agitation, inability to feel joy, lack of motivation and excitement, social withdrawal and apathy. [1]
Read More
04.21.2022
Cold medicine has been trusted by Vietnamese people for half a century
Read More
03.11.2022
Live healthy every day with Bepharco
Read More
06.24.2019
Bepharco coordinated with Gedeon Richter to organize a scientific conference in Hanoi
Read More
«
‹
20
30
31
32
33
34
35